IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

New Leaf Venture Partners, L.L.C.

Q4 2022 Holdings

Filed 2023-02-06 | 17 holdings | $138.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Arvinas Inc(ARVN)COM04335A105$44.1M1,289,52131.9%
Rallybio CorporationCOM75120L100$21.7M3,301,60315.7%
Deciphera Pharmaceuticals Inc(DCPHEUR)COM24344T101$19.8M1,209,57114.4%
Edgewise Therapeutics Inc(EWTX)COM28036F105$13.9M1,553,66110.1%
Dice Therapeutics IncCOM23345J104$11.6M371,6938.4%
Cogent Biosciences Inc.(COGT)COM19240Q201$5.8M501,5304.2%
Passage BIOCOM702712100$3.4M2,497,9222.5%
Amryt Pharma PLCSPONSORED ADS03217L106$3.3M449,7372.4%
Alector Inc(ALEC)COM014442107$3.1M339,5692.3%
Crinetics Pharmaceuticals Inc(CRNX)COM22663K107$2.6M141,0001.9%
Rocket Pharmaceuticals Inc(RCKT)COM77313F106$2.3M118,2421.7%
Harpoon Therapeutics IncCOM41358P106$2.3M3,156,6991.7%
Chimerix Inc(CMRXEUR)COM16934W106$2.3M1,224,6001.6%
Aravive Inc(VSAREUR)COM03890D108$1.2M946,4230.9%
X4 Pharmaceuticals Inc(ASNSUSD)COM98420X103$332.7K335,0000.2%
Avrobio IncCOM05455M100$225.0K315,5500.2%
Iterum Therapeutics PLCSHSG6333L200$81.6K97,0840.1%